Home » Topics » BioWorld Science

BioWorld Science
RSS

Discovery of novel antisense oligonucleotides for the treatment of prion disease

Aug. 22, 2019

Shinkei Therapeutics files IND application with the FDA for MR-201

Aug. 22, 2019

Phase I data presented for CM-101 subcutaneous formulation

Aug. 22, 2019

Glenmark receives approval for combination of remogliflozin and metformin in India

Aug. 22, 2019

MyoKardia initiates dosing in phase I study of MYK-224 for hypertrophic cardiomyopathy

Aug. 22, 2019

First patient enrolled in phase II study of AR-201 for egg allergy

Aug. 22, 2019

MSH3 linked to somatic expansion and disease phenotype in Huntington's disease and DM1

Aug. 22, 2019

Targeting NuRD for derepression of fetal hemoglobin in hemoglobinopathies

Aug. 22, 2019

PDX model allows study of hepatitis B virus in hepatocellular carcinoma

Aug. 22, 2019

Anti-RSV agent ziresovir demonstrates promising preclinical profile

Aug. 22, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...